PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Drug ReportsVorhyaluronidase alfa
Hyaluronidase (human recombinant)
Hyaluronidase (human recombinant) is an enzyme pharmaceutical. It is currently being investigated in clinical studies.
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
Therapeutic Areas
No data
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
No data
Labels
FDA
EMA
Brand Name
Status
Last Update
darzalex fasproBiologic Licensing Application2024-08-08
herceptin hylectaBiologic Licensing Application2024-11-21
hylenex recombinantBiologic Licensing Application2024-01-24
phesgoBiologic Licensing Application2024-12-02
vyvgart hytruloBiologic Licensing Application2024-08-14
Indications
FDA
EMA
No data
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
No data
HCPCS
No data
Clinical
Clinical Trials
186 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
No data
Indications Phases 3
No data
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
NeoplasmsD009369C8011
Skin neoplasmsD012878EFO_0004198C4411
MelanomaD00854511
Cutaneous malignant melanomaD00009614211
Non-small-cell lung carcinomaD00228911
Lung neoplasmsD008175C34.9011
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Breast neoplasmsD001943EFO_0003869C50112
Non-hodgkin lymphomaD008228C85.911
Multiple myelomaD009101C90.011
LymphomaD008223C85.911
Plasma cell neoplasmsD05421911
B-cell lymphomaD01639311
Prostatic neoplasmsD011471C6111
RecurrenceD01200811
CarcinomaD002277C80.011
Ovarian neoplasmsD010051EFO_0003893C5611
Show 3 more
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Covid-19D000086382U07.111
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameHyaluronidase (human recombinant)
INNvorhyaluronidase alfa
Description
Hyaluronidase (human recombinant) is an enzyme pharmaceutical. It is currently being investigated in clinical studies.
Classification
Enzyme
Drug classenzymes
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)
Identifiers
PDB
CAS-ID
RxCUI
ChEMBL IDCHEMBL1201718
ChEBI ID
PubChem CID
DrugBank
UNII ID743QUY4VD8 (ChemIDplus, GSRS)
Target
No data
Variants
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Plot placeholder
Mock data
Subscribe for the real data
Additional graphs summarizing 1,487 documents
View more details
Safety
Black-box Warning
Black-box warning for: Herceptin hylecta, Phesgo
Adverse Events
Top Adverse Reactions
Plot placeholder
Mock data
Subscribe for the real data
14,472 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use